Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAC-VAC: Autologous Vaccines in Metastatic Melanoma
NCT00436930Phase 2Completed
- Sponsor
- Hoag Memorial Hospital Presbyterian
- Start
- Dec 2006
- Primary completion
- Oct 2012
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Intus in melanoma, sponsored by Hoag Memorial Hospital Presbyterian. Started Dec 2006; status: completed.
02
Drugs
Intus
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00436930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436930.